Found 1216 matching trials
Neuropsychiatric Post-Acute Sequelae of SARS-CoV-2 (PASC) Using TSPO Positron Emission Tomography (PET) and MRI N/A The overarching goal of this study is to develop PET/MR techniques for the ...
Show More Status
Active Not Recruiting
Location
NYU Langone Health
Learn More & Join Trial
De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA PHASE2 This phase II trial examines the use of blood-based biomarkers is to help i...
Show More Location
Mayo Clinic in Arizona
Learn More & Join Trial
Transcriptional and Epigenetic Program of PCOS Women N/A The main goal is to reveal differences in global gene expression in two dif...
Show More Status
Active Not Recruiting
Location
AdventHealth Translational Research Institute
Learn More & Join Trial
QoL and Cognitive Function in Patients With Hypoparathyroidism N/A Hypoparathyroidism (HypoPT) is a disease with inadequate production of para...
Show More Location
Clinic for Osteoporosis, Aarhus University Hospital
Learn More & Join Trial
NaF Positron Emission Tomography/Computed Tomography (PET/CT)Imaging to Assess Treatment Responsiveness to TAK-700 in Patients With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastasis PHASE2 The purpose of this study is to assess whether NaF PET/CT scans can be used...
Show More Location
University of Wisconsin Carbone Cancer Center
Learn More & Join Trial
Dasatinib and Quercetin With CAR-T Therapy for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma PHASE2 This phase II trial tests how well giving dasatinib and quercetin with cycl...
Show More Location
Mayo Clinic in Rochester
Learn More & Join Trial
Autologous CD8+ and CD4+ Transgenic T Cells Expressing High Affinity KRASG12V Mutation-Specific T Cell Receptors (FH-A11KRASG12V-TCR) in Treating Patients With Metastatic Solid Tumor Cancers With KRAS G12V Mutations PHASE1 This phase I trial studies the side effects and best dose of autologous CD8...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
ABBV-383 for the Treatment of Relapsed Refractory Waldenström Macroglobulinemia PHASE1 This phase I/II trial studies the side effects and best dose of ABBV-383 an...
Show More Location
Mayo Clinic in Rochester
Learn More & Join Trial
Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR After a Myeloablative Conditioning Regimen to Treat Patients With Advanced Cancer PHASE1 This phase I clinical trial evaluates the safety and feasibility of adminis...
Show More Location
UCLA / Jonsson Comprehensive Cancer Center
Learn More & Join Trial
Testing the Addition of Radiation Therapy to the Immune Therapy Treatment for ES-SCLC PHASE2 This phase II trial compares the effect of adding radiation therapy to the ...
Show More Location
Zhejiang Cancer Hospital
Learn More & Join Trial